Condition: Venous Thromboses · Venous Disease · Venous Leg Ulcer · Sponsor: W.L.Gore & Associates
This study is a prospective, non-randomized, multicenter, single-arm, clinical study to evaluate the performance, safety and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic iliofemoral venous obstruction.
This description comes directly from the study's public registry record.
Carl Conway · 6175952277 · cconway@wlgore.com
Leonard Resecker · 62356520649287074940 · lresecke@wlgore.com
Always discuss trial participation with your own doctor first.
| Stanford University School of Medicine | Stanford, California, United States | Recruiting |
| Advanced Heart and Vein (ClinRe) | Thornton, Colorado, United States | Withdrawn |
| Vascular Care Group | Darien, Connecticut, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| Manatee Memorial Hospital | Bradenton, Florida, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Vascular Care Group | Wellesley, Massachusetts, United States | Recruiting |
| University of Michigan Hospital | Ann Arbor, Michigan, United States | Recruiting |
| Englewood Hospital & Med Center | Englewood, New Jersey, United States | Recruiting |
| Holy Name Medical Center | Teaneck, New Jersey, United States | Withdrawn |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05489588